KIMBERLY DOOLIN: Open Payments
NPI 1982171625 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 9 payments from 5 companies in 2025. Trend: 2023 $320 · 2024 $360 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Lilly USA, LLC | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, MOUNJARO, COBENFY, UZEDY, INGREZZA.
Industry payments across MO — which companies pay providers there.
